TO INNOVATIONS

FRIDAY 28 OCTOBER 2016 ORAL ABSTRACT SESSIONS
14.10 [OA-417-28]
The development of a lung health awareness-raising programme in Masindi province, Uganda
R Jones, B Kirenga, F van Gemert (United Kingdom, Uganda)
14.20 [OA-418-28]
Assessment of asthma control and risk factors for poor asthma control among patients seen at a referral hospital, Addis Ababa, Ethiopia
T H Gebremariam, A B Binegdie, A W Ashagre, A S Mitiku, K G Gebrehiwot, D K Huluka, C B Sherman, N W Schluger (Ethiopia,
United States of America)
14.30 [OA-419-28]
Oxygen therapy in a resource-limited setting: a time-series analysis of oxygen requirement and use in acutely unwell adults in Malawi
A Chick, S Mirdamadi, M Nyirenda, A Munyenyembe, M Kasonya, B Zimbah, W Nyirenda, G Zgomba, S Aston, J Rylance, Investigation
of Oxygen use: a Time-course Analysis (IOTA) (Malawi, United Kingdom)
14.40 [OA-420-28]
Diagnostic performance of chest computed tomography for the localisation of bleeding site in patients with hemoptysis
Y-S Kwon, H J Seon, H-J Shin (Korea, Republic of)
ORAL ABSTRACT SESSION 17 3 15:15-16:45 3 SESSION ROOM 1A
HIV-TB LATE-BREAKER SESSION
Chair: Amy Bloom, Keren Middelkoop, Katharina Kranzer (Union HIV section officers), Paula I Fujiwara (The Union) – Section: HIV
15.15 [OA-3048]
Potential impact of antiretroviral therapy on tuberculosis incidence among people with and without HIV – 26 countries,
Sub-Saharan Africa, 2010–2014
D Surie, M W Borgdorff, K P Cain, E S Click, K M DeCock, C M Yuen (United States of America, Kenya)
15.30 [OA-3106]
Do high expression MIF alleles confer protection against active tuberculosis?
D Reid, S Shenoi, R Singh, M Wang, V Patel, R Das, K Hiramen, M Moosa, L Leng, F Eksteen, A Moll, T Ndung’u, V Kasprowicz, G Friedland,
R Bucala (United States of America, South Africa)
15.45 [OA-3110]
Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: insight into strategy
for tuberculosis preventive therapy
B Karo, G Krause, S Castell, C Kollan, O Hamouda, W Haas, The ClinSurv HIV Study Group (Germany)
16.00 [OA-2981]
Effectiveness of combination intervention package on initiation of antiretroviral therapy among patients with tuberculosis and HIV (TB/HIV)
A Howard, S Saito, K Frederix, B Pitt, L B Maama, E Hayes-Larson, W El-Sadr, Y Hirsch-Moverman (United States of America, Lesotho)
16.15 [OA-3112]
Community-based TB screening and HIV testing for ex-miners in Lesotho
R Chang, S Stender, L Maama, E Kobayashi, S Reinhardt, A Singh, P Akugizibwe (United States of America, South Africa, Lesotho, Rwanda)
16.30 [OA-3012]
Accessibility to HIV-TB services is a facilitator for TB screening amongst PLHIVs: a case study from Central India
M BISWAS, T Nale, P Sharma, A Kharate (India)
ORAL ABSTRACT SESSION 18 3 15:15-16:45 3 SESSION ROOM 3B
FRIDAY 28 OCT
THE TIDE IS HIGH: TB AND CO-MORBIDITIES
Co-chairs: Megan Murray (United States of America), Srinath Satyanarnyana (India) – Section: Tuberculosis/Adult and Child Lung Health/Tobacco Control
15.15 [OA-421-28]
Tuberculosis and diabetes: trends in hospitalisations and impact on health care costs in the United States
M Pearson (United States of America)
15.25 [OA-422-28]
Risk of death and/or poor treatment outcomes among persons with tuberculosis and diabetes in high TB and diabetes burden countries:
a systematic review
C Ugarte-Gil, P Huangfu, F Pearson, J Golub, J Critchley (Peru, United States of America, United Kingdom)
15.35 [OA-423-28]
Chronic kidney disease progression and risk of tuberculosis: a cohort study
P Cho, M-Y Wu, C-Y Wu, Y-J Shih, C-C Chan, H-H Lin (United States of America, Taiwan)
15.45 [OA-424-28]
Prevalence and clinical relevance of respiratory viruses among tuberculosis patients and household controls in Tanzania
F Mhimbira, H Hiza, J Hella, T Maroa, E Mbuba, M Chiryamkubi, S Gagneux, L Fenner (Tanzania, United Rep., Switzerland)
26-29 OCTOBER 2016 - LIVERPOOL - UNITED KINGDOM
125